Literature DB >> 12841541

Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting.

D Micić1, M Sumarac-Dumanović, Dj Macut, A Kendereski, S Zoric, V Popović, G Cvijović, C Dieguez, F F Casanueva.   

Abstract

Controversial data were reported on GH response to different provocative stimuli in obese patients with polycystic ovary syndrome (PCOS). The objective of our study was to assess the effect of short-term fasting on GH response to combined stimulus with GHRH+GH-releasing peptide-6 (GHRP-6) in obese patients with PCOS and possible relation with leptin and insulin changes during fasting. Twelve obese PCOS women and nine obese control women participated in 3-day fasting. GH response, IGF-I, insulin and leptin were measured after GHRH+ GHRP-6, before and after short-term fasting. Obese PCOS patients had significantly greater GH peak after GHRH+GHRP-6 before fasting. Enhanced response to GH stimulation was found after fasting without substantial differences between obese PCOS and obese controls. Insulin and leptin significantly decreased, while insulin sensitivity significantly improved in both groups during fasting. In conclusion, obese PCOS patients have peculiar type of GH response to GHRH+GHRP-6 before fasting, possibly due to enhanced sensitivity of somatotrophs. Observed changes in insulin and leptin may participate in modulation of enhanced GH response after short-term fasting to GHRH+GHRP-6 in PCOS and obese controls.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841541     DOI: 10.1007/bf03345181

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  44 in total

1.  Physical activity or food intake prior to testing did not affect the reproducibility of GH secretion elicited by GH releasing hormone plus GH-releasing hexapeptide in normal adult subjects.

Authors:  Vera Popovic; Sandra Pekic; Mirjana Simic; Svetozar Damjanovic; Dragan Micic; Carlos Dieguez; Felipe F Casanueva
Journal:  Clin Endocrinol (Oxf)       Date:  2002-01       Impact factor: 3.478

2.  Role of growth hormone (GH)-releasing hormone and somatostatin on leptin-induced GH secretion.

Authors:  E Carro; R M Señarís; L M Seoane; L A Frohman; A Arimura; F F Casanueva; C Diéguez
Journal:  Neuroendocrinology       Date:  1999-01       Impact factor: 4.914

3.  Leptin regulates GH secretion in the rat by acting on GHRH and somatostatinergic functions.

Authors:  D Cocchi; V De Gennaro Colonna; M Bagnasco; D Bonacci; E E Müller
Journal:  J Endocrinol       Date:  1999-07       Impact factor: 4.286

Review 4.  Growth hormone and sex steroids. Interactions in puberty.

Authors:  N Mauras
Journal:  Endocrinol Metab Clin North Am       Date:  2001-09       Impact factor: 4.741

5.  Incomplete modified fast in obese early pubertal girls leads to an increase in 24-hour growth hormone concentration and a lessening of the circadian pattern in leptin.

Authors:  Josephine Z Kasa-Vubu; Ariel Barkan; Pamela Olton; Teerin Meckmongkol; Nichole E Carlson; Carol M Foster
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

6.  Metabolic and endocrine consequences of acute suppression of FFAs by acipimox in polycystic ovary syndrome.

Authors:  M Ciampelli; G Muzj; F Leoni; D Romualdi; C Belosi; R M Cento; A Lanzone
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

7.  Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome.

Authors:  D Micić; A Kendereski; V Popović; M Sumarac; S Zorić; D Macut; C Dieguez; F Casanueva
Journal:  Clin Endocrinol (Oxf)       Date:  1996-10       Impact factor: 3.478

8.  A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test.

Authors:  A Leal; M Lage; V Popovic; E Torres; H P F Koppeschaar; C Paramo; D Micic; R V Garcia-Mayor; C Dieguez; F F Casanueva
Journal:  Clin Endocrinol (Oxf)       Date:  2002-09       Impact factor: 3.478

Review 9.  Growth hormone-releasing hormone: clinical studies and therapeutic aspects.

Authors:  L C Low
Journal:  Neuroendocrinology       Date:  1991       Impact factor: 4.914

10.  Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries.

Authors:  G M Prelević; M I Wurzburger; L Balint-Perić; J Ginsburg
Journal:  Horm Res       Date:  1992
View more
  1 in total

Review 1.  Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights.

Authors:  Antonio Mancini; Carmine Bruno; Edoardo Vergani; Claudia d'Abate; Elena Giacchi; Andrea Silvestrini
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.